Chinese scientists have used CRISPR Therapeutics (Nasdaq: CRSP) technology to genetically engineer cells in 86 cancer and HIV patients. The stock price leaped $5.03 to close at $38.78.
Chinese scientists use CRISPR technology
January 23, 2018 at 16:39 PM EST
